IP Library Granted Patent US 11,420,061
Granted Patent B2
US 11,420,061 · App. 16/865,668 · Granted Aug 23, 2022

Biased neuromodulation lead and method of using same

Inventors: Anthony V. Caparso (North Ridgeville, OH); Josh Nickols (Louisville, KY)
Assignee: XII MEDICAL, INC.
A61N1/3611A61N1/37229
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,420,061
App. No.
16/865,668
Granted
Aug 23, 2022
Kind
B2
Abstract

A neuromodulation lead that is biased towards a substantially omega shape when fully deployed is provided. The neuromodulation lead includes a left set of electrodes disposed on a left portion of the lead body of the neuromodulation lead and a right set of electrodes disposed on a right portion of the lead body of the neuromodulation lead. The neuromodulation lead can be positioned in the plane between the genioglossus muscle and the geniohyoid muscle.

Claims (19)

1. A neuromodulation device comprising:

a neuromodulation lead comprising:

a lead body having a left portion, a right portion, and an intermediate portion therebetween,

a left set of electrodes disposed on the left portion of the lead body, and

a right set of electrodes disposed on the right portion of the lead body,

wherein the left set of electrodes and the right set of electrodes are oriented along a plane and are configured to align with left nerve branches and right nerve branches of a hypoglossal nerve, respectively, when the neuromodulation device is implanted in a patient, and

wherein the intermediate portion comprises a preformed bend such that the intermediate portion is outside of the plane, and such that when the lead body is placed between a geniohyoid muscle and a genioglossus muscle in a patient with the intermediate portion arranged inferior to the left set of electrodes and the right set of electrodes, the intermediate portion is configured to push the left set of electrodes and the right set of electrodes further cranially into the genioglossus muscle; and

a connector having a proximal end and a distal end, wherein the distal end of the connector is coupled to the lead body; and

an antenna electrically coupled to the neuromodulation lead via the connector,

wherein the lead body has a proximal portion and a distal portion, the proximal portion extending between the distal end of the connector and the distal portion, and the distal portion comprising the left, right, and intermediate portions and the left and right electrode sets.

2. The neuromodulation device of claim 1 , wherein the locations of the left and right sets of electrodes on the respective left and right portions of the lead body are based on the locations of respective left and right stimulation target sites comprising the hypoglossal nerve trunk, distal branches of the hypoglossal nerve, or both.

3. The neuromodulation device of claim 1 , wherein the locations of the left and right sets of electrodes on the respective left and right portions of the lead body are based on the locations of respective left and right stimulation sites comprising nerve branches that innervate horizontal fibers within the genioglossus muscle, nerve branches that innervate oblique fibers within the genioglossus muscle, or both.

4. The neuromodulation device of claim 1 , further comprising an ultrasound marker disposed on the lead body.

5. The neuromodulation device of claim 1 ,

wherein the antenna is configured to produce an induced current in response to being disposed in an electromagnetic field, the antenna comprising a substrate having an upper surface and a lower surface, an upper coil comprising a plurality of coil turns disposed on the upper surface of the substrate, and a lower coil comprising a plurality of coil turns disposed on the lower surface of the substrate, wherein the upper and lower coils are electrically connected to each other in parallel.

6. The neuromodulation device of claim 5 , further comprising electronics operably coupled to the antenna and configured to control the application of stimulation energy via one or more of the electrodes, wherein the antenna is configured to supply electrical current to the electronics to power the electronics.

7. The neuromodulation device of claim 6 , wherein the antenna comprises a flexible circuit board, the upper and lower coils being etched from conductive layers laminated onto the substrate, wherein the electronics comprise one or more electronic components mounted on a portion of the flexible circuit board, wherein the flexible circuit board is configured to electrically connect the one or more electronic components to the antenna.

8. The neuromodulation device of claim 1 , wherein the lead body, connector, and antenna are configured to be implanted at a submental region of a human patient.

9. The neuromodulation device of claim 1 , wherein the proximal portion of the lead body is configured to fold over itself when the neuromodulation device is implanted.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2024
From: SOOSE, RYAN
To: ENHALE MEDICAL, INC.
Reel/Frame 067840/0872 →
CHANGE OF NAME Recorded Jun 8, 2021
From: ENHALE MEDICAL, INC.
To: XII MEDICAL, INC.
Reel/Frame 056523/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2020
From: CAPARSO, ANTHONY; NICKOLS, JOSH
To: ENHALE MEDICAL, INC.
Reel/Frame 053802/0570 →
Continuity (2)
Provisional Application 62915194 · Oct 15, 2019
Related Publication 20210106824A1 · Apr 15, 2021
Cited By (25)
US 12,274,494 US 12,311,170 US 12,343,528 US 12,427,307 US 12,434,058 US 12,440,677 US 12,491,366 US 12,521,562 US 12,521,565 US 12,558,146 US 12,558,542 US 12,564,726 US 12,582,822 US 12,589,246 US 12,589,256 US 12,611,545 US 12,623,078 US 12,623,088 US 12,636,497 US 12,654,023 US 12,667,733 US 12,678,215 US 12,685,873 US 12,691,296 US 12,702,470